(IN BRIEF) Scientists from the Luxembourg Institute of Health, in collaboration with national clinical and research partners, have developed a functional profiling approach that could significantly enhance personalized treatment strategies for metastatic colorectal cancer. By using patient-derived spheroids—three-dimensional tumour models … Read the full press release →
Posted in Business, Healthcare, Industrial, Investment, Luxembourg, Management, Science, Technology
Tagged anti EGFR therapy, cancer drug screening, ERBB2 ERBB3 pathways, functional profiling, Hôpitaux Robert Schuman, Laboratoire National de Santé, Luxembourg Institute of Health, Luxembourg National Research Fund, metastatic colorectal cancer, New Study Demonstrates Predictive Power of Patient-Derived Tumour Models for Personalised Colorectal Cancer Therapy, npj Precision Oncology, oncology research, patient-derived spheroids, personalised medicine, precision oncology, tumour models, Victoria El-Khoury, Yong-Jun Kwon
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This collaboration includes an exclusive global license (excluding China) to develop and commercialize Hengrui’s advanced PARP1 inhibitor, HRS-1167. Additionally, there is … Read the full press release →
Posted in Germany, Healthcare, Pharma & Biotech
Tagged ADC, antibody-drug conjugate, ATM, ATR, Cancer, CEACAM5-targeting ADC, Claudin-18.2, Danny Bar-Zohar, DDR cascade, DNA-PK, Frank Jiang, Hengrui, HRS-1167, inhibitor, Jiangsu Hengrui Pharmaceuticals Co. Ltd., M9140, Merck, metastatic colorectal cancer, oncology, PARP, PARP1, poly (ADP-ribose) polymerase 1, SHR-A1904
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
